Carregant...
Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy
Dexamethasone, a widely used corticosteroid, has recently been reported as the first drug to increase the survival chances of patients with severe COVID-19. Therapeutic agents, including dexamethasone, are mostly transported through the body by binding to serum albumin. Herein, we report the first s...
Guardat en:
| Publicat a: | bioRxiv |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cold Spring Harbor Laboratory
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7386489/ https://ncbi.nlm.nih.gov/pubmed/32743572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.07.21.212704 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|